US expert panel endorses Johnson & Johnson's one-dose COVID-19 vaccine
After daylong discussions, the FDA panelists voted unanimously that the benefits of the vaccine outweighed the risks for adults. If the FDA agrees, shipments of a few million doses could begin as early as Monday.